Cargando…
Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
BACKGROUND: Alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition predisposing individuals to chronic obstructive pulmonary disease (COPD). The treatment is generally extrapolated from COPD unrelated to AATD; however, most COPD trials exclude AATD patients; thus, this study sought to sys...
Autores principales: | Edgar, Ross G, Patel, Mitesh, Bayliss, Susan, Crossley, Diana, Sapey, Elizabeth, Turner, Alice M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422329/ https://www.ncbi.nlm.nih.gov/pubmed/28496314 http://dx.doi.org/10.2147/COPD.S130440 |
Ejemplares similares
-
Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020) -
Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin Deficiency
por: Spittle, Daniella A., et al.
Publicado: (2023) -
Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
por: Stockley, Robert A, et al.
Publicado: (2016) -
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives
por: Quinn, Mark, et al.
Publicado: (2020) -
Alpha-1 antitrypsin deficiency: an update on clinical aspects of diagnosis and management
por: Santos, Gabriela, et al.
Publicado: (2020)